Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2026-04-23 Earnings Release
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Ipsen enregistre une forte croissance de ses ventes au premier trimestre 2026 et confirme ses objectifs annuels
Earnings Release Classification · 1% confidence The document is an Ipsen press release dated 23 April 2026 announcing first‐quarter 2026 sales results, segment performance tables, 2026 guidance, R&D pipeline updates, and details of a conference call. It is an initial public announcement of quarterly financial results, matching the definition of an Earnings Release. Q1 2026
2026-04-23 French
Ipsen delivers strong sales in the first quarter of 2026 and confirms its full-year guidance
Earnings Release Classification · 1% confidence The document is a press release dated 23 April 2026 from Ipsen presenting its first-quarter 2026 sales results, key performance highlights, full-year guidance confirmation, pipeline updates, and conference call details. It provides initial quarterly financial metrics (sales by segment and geography) and guidance rather than a full interim report with complete financial statements. This matches the definition of an Earnings Release (ER) – an initial announcement of quarterly/periodical financial results. Q1 2026
2026-04-23 English
Ipsen S.A. - Informations concernant la tenue de l’Assemblée Générale Mixte du 13 mai 2026
Regulatory Filings Classification · 1% confidence The document is a press release notifying shareholders of the upcoming Mixed General Meeting (AGM) of Ipsen S.A. on May 13, 2026, and advising on how to access and consult the preparatory materials (notice of meeting, convocation brochure, agenda, and resolutions). It does not itself contain the AGM materials or full meeting content, nor voting results, dividend notices, or financial statements. It is strictly an informational regulatory announcement about the meeting and the availability of documents. No category precisely matches a “notice of meeting,” so it falls into the fallback “Regulatory Filings” category (RNS).
2026-04-22 French
Ipsen S.A. - Information relating to the holding of the Combined Shareholders’ Meeting of 13 May 2026
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a regulated press release notifying shareholders of the upcoming Combined Shareholders’ Meeting, providing the convening notice, agenda items, draft resolutions, and instructions for accessing preparatory documents. It is not reporting voting results (DVA), nor publishing a financial report (10-K, IR), nor announcing management changes (MANG) outside of a meeting context. It closely matches a proxy solicitation/information statement (PSI) in which shareholders are provided with meeting materials and invited to vote.
2026-04-22 English
Ipsen announces that Beech Tree has obtained an exemption from the obligation to submit a public tender offer
M&A Activity Classification · 1% confidence The document is a corporate press release announcing that a major shareholder (Beech Tree) has received an exemption from the obligation to launch a mandatory public tender offer under French takeover rules. It outlines the regulatory decision by the AMF and related governance agreements tied to takeover law. This falls under announcements related to takeover bids rather than financial results or management changes. Therefore, it is classified as M&A Activity (Code: TAR).
2026-04-03 English
Ipsen annonce l’obtention par Beech Tree d’une dérogation à l’obligation de déposer une offre publique
Regulatory Filings Classification · 1% confidence The document is a press release from Ipsen announcing that its major shareholder Beech Tree has obtained from the AMF a waiver from the obligation to file a mandatory takeover offer. It describes corporate governance arrangements and a regulatory decision rather than presenting financial results, detailing a shareholder vote, a takeover bid, or a full report. It does not correspond to share issuance or director dealings, nor is it a formal proxy statement, earnings release, or other specific category. It is a regulatory announcement of an AMF decision that does not neatly fit into any of the narrower categories, making the fallback “Regulatory Filings (RNS)” the most appropriate classification.
2026-04-03 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.